Results 11 to 20 of about 50,854 (230)

Clinical challenges of paraneoplastic endocrine metabolic syndromes: An illustrative example

Journal of Clinical and Translational Endocrinology Case Reports
Background/objective: Paraneoplastic endocrine metabolic syndromes are rare, but clinically significant manifestations of underlying malignancies, often complicating clinical course and impacting treatment outcomes.
Srushti Shankar, Sumal S. Sundar, Madhumati S. Vaishnav, Leena Lekkala, Chandraprabha Siddalingappa, Kavitha Muniraj, Thummala Kamala, Reshma B. Vijay, Vasanthi Nath, Mandyam D. Chitra, Pushpa Ravikumar, Siddartha Dinesha, Tejeswini Deepak, Srikanta Sathyanarayana   +13 more
doaj   +3 more sources

Endocrine paraneoplastic syndromes in patients with neuroendocrine neoplasms [PDF]

Endocrine, 2018
Our aim was to assess the prevalence of endocrine paraneoplastic syndromes (EPNS) in neuroendocrine neoplasms (NENs) and estimate its impact on patient outcomes.This is a retrospective analysis of 834 patients with NENs (611 gastrointestinal, 166 thoracic, 57 of unknown and various other primary origin). We included 719 consecutive NEN patients treated
Kosmas Daskalakis, Eleftherios Chatzelis, Marina Tsoli, Nektaria Papadopoulou‐Marketou, Georgios K. Dimitriadis, Apostolos V. Tsolakis, Gregory Kaltsas   +6 more
semanticscholar   +8 more sources

Mechanisms of autoimmune-mediated paraneoplastic syndromes: immune tolerance and disease pathogenesis [PDF]

Frontiers in Immunology
Paraneoplastic syndromes represent a clinically heterogeneous group of disorders that arise in cancer patients. Although their underlying mechanisms are only partly understood, immune or endocrine mechanisms are believed to play key roles.
César Pérez-Bucio, Anish Behere, Nils Landegren   +2 more
doaj   +3 more sources

Cutaneous paraneoplastic syndromes. Dermatological manifestations associated with malignancies [PDF]

Journal of Education, Health and Sport
Introduction and purpose: Paraneoplastic syndromes (PS) are conditions associated with malignant tumours whose mechanism of onset is not fully understood.
Paulina Polańska, Marta Gruszka, Martyna Zakrocka, Maria Kubicka   +3 more
doaj   +4 more sources

Endocrine paraneoplastic syndromes in lung cancer: A call for clinical vigilance (Review). [PDF]

Mol Clin Oncol
Endocrine paraneoplastic syndromes (PNS) are uncommon but clinically impactful manifestations associated with malignancies, particularly lung cancer, most notably small-cell lung cancer.
Koloutsou ME, Soura M, Andreikos D, Spandidos DA, Yavropoulou MP, Georgakopoulou VE.   +5 more
europepmc   +4 more sources

7901 Clinical Challenges Of Paraneoplastic Endocrine Metabolic Syndromes: An Illustrative Example [PDF]

J Endocr Soc
Disclosure: S. Shankar: None. S.S. Sundar: None. M.S. Vaishnav: None. K. Thummala: None. L. Lekkala: None. S. Srikanta: None. K. Muniraj: None. T. Deepak: None. R.B. Vijay: None. V. Nath: None. C. Siddlingappa: None. P. Ravikumar: None. M.D. Chitra: None.
Srushti Shankar, Sumal Sri Sundar, Madhumati S. Vaishnav, Kamala Thummala, Leena Lekkala, S. Srikanta, Kavitha Muniraj, Tejeswini Deepak, Reshma Vijay, Vasanthi Nath, Chandraprabha Siddlingappa, Pushpa Ravikumar, M Chitra   +12 more
europepmc   +4 more sources

Progesterone Receptor Antagonists – A Novel Treatment for Severe Hyponatremia from the Endocrine Paraneoplastic Syndrome [PDF]

, 2021
Hyponatremia related to ectopic secretion of cancer cells of argininevasopressin (AVP) or atrial natriuretic peptide (ANP) is most commonlycaused by small cell lung cancer.
Jerome H. Check, Diane Check, Michael P. Dougherty   +2 more
openalex   +3 more sources

Seronegative Paraneoplastic Opsoclonus-Myoclonus-Ataxia Syndrome Secondary to Low Volume Endocrine-Sensitive Malignancy of Likely Breast Origin. [PDF]

Curr Oncol
Berger G, Jackson-Tarlton C, Rayson D, Silver A, Walsh M, Drohan A.   +5 more
europepmc   +3 more sources

Multiple endocrine paraneoplastic syndromes in a patient with lung malignancy [PDF]

, 2015
Alex Lewis, Isha Malik, Kelly Cheer, Cuong Duy Dang   +3 more
openalex   +2 more sources

IL-6-producing Renal Cell Carcinoma Causing Renal and Endocrine Paraneoplastic Syndromes

Internal medicine, 2019
An 83-year-old man with stable chronic kidney disease (CKD) exhibited a sudden increase in urinary N-acetyl-β-D-glucosaminidase and protein excretion, suggesting aggravated kidney damage. Simultaneously, he lost diabetic control, requiring up to 54 units
Akira Okada, T Higashihara, Taiko Kusano, Koji Takemura, Hanako Saigusa, Sayako Maruno, Mimiko Matsumura, Takeo Suzuki, Akira Shimizu, Hideki Takano   +9 more
openalex   +3 more sources